JB Chemicals and Pharmaceuticals: Should You Buy, Hold, or Sell Right Now?
- September 3, 2026
- Posted by: Kunal Singla
- Category: Market
JB Chemicals share price Rs 2,408.90 (NSE), near its 52-week high. 52-week range Rs 1,638.50 to Rs 2,525.50. FY26 profit up 7.6% YoY to Rs 709.47 crore.
Quick Answer
JB Chemicals and Pharmaceuticals share price is trading around Rs 2,409, close to its 52-week high of Rs 2,525.50 and well above its 52-week low of Rs 1,638.50. For the full year FY26, revenue grew 6.4 percent year on year to Rs 4,207.94 crore, with net profit up 7.6 percent to Rs 709.47 crore; specific Q1 FY27 figures were not independently confirmed across sources at the time of writing, so the most recently verified quarter is Q4 FY26. The stock trades at 54.6 times earnings, a premium to the pharmaceutical sector average near 38 times. Investors who value the company’s debt free balance sheet and steady growth may see the current level as reasonable, while others may want confirmed Q1 FY27 numbers before adding fresh exposure.
JB Chemicals and Pharmaceuticals share price is trading close to its 52-week high of Rs 2,525.50, with JB Chemicals share price near Rs 2,409 on the NSE, well above its 52-week low of Rs 1,638.50. With the stock near its highs following steady full-year growth, investors are asking whether this branded pharmaceutical company is a stock to buy right now, a hold, or a sell given the premium valuation.
This JB Chemicals stock analysis walks through the most recently confirmed results, valuation against the pharmaceutical sector, shareholding pattern and the technical setup, using figures sourced from company disclosures and public filings. Specific Q1 FY27 quarterly figures were not consistently confirmed across sources at the time of writing, so this article references the most recently verified full-year and quarterly data.
Click Here – Get Free Investment Predictions
About JB Chemicals and Pharmaceuticals
Keep this backdrop in mind when reading the rest of this JB Chemicals share price review. Before deciding on JB Chemicals share price, it helps to understand the underlying business. JB Chemicals and Pharmaceuticals Ltd. is an Indian pharmaceutical company with a diversified portfolio spanning domestic branded formulations, international formulations, active pharmaceutical ingredients, and a growing contract development and manufacturing (CDMO) business. The company has built a reputation for strong domestic brand performance alongside export operations across multiple international markets.
JB Chemicals has been expanding through both organic brand growth and strategic acquisitions, maintaining a debt free balance sheet even while investing in its CDMO capabilities, which management sees as a longer-term growth driver alongside the core branded formulations business.
JB Chemicals and Pharmaceuticals Share Price Today: Key Levels
This snapshot is the starting point for any JB Chemicals share price discussion. The table below summarises where JB Chemicals share price stands right now against its recent trading range and market value.
| Metric | Value |
|---|---|
| JB Chemicals CMP (NSE) | Rs 2,408.90 |
| JB Chemicals CMP (BSE) | Rs 2,412.25 |
| 52-Week High | Rs 2,525.50 |
| 52-Week Low | Rs 1,638.50 |
| Market Capitalisation | Approximately Rs 38,731 crore |
| NSE Volume (latest session) | Very low, near 52-week high |
JB Chemicals share price is trading close to its 52-week high, reflecting sustained investor confidence following steady full-year revenue and profit growth for this debt free pharmaceutical company.
Check the Univest Screener for Live Stock Data
JB Chemicals and Pharmaceuticals Financial Performance
These figures anchor the rest of this JB Chemicals share price review. Track this line item closely if you are following JB Chemicals share price closely. The JB Chemicals share price trend is closely tied to how these numbers evolve each quarter. In its most recently confirmed quarter, JB Chemicals reported Q4 FY26 (March 2026 quarter) revenue of Rs 916.21 crore, with net profit of Rs 101.37 crore. For the full year FY26, the company reported revenue of Rs 4,207.94 crore, up 6.4 percent year on year, with net profit of Rs 709.47 crore, up 7.6 percent, continuing a steady multi-year growth trend across its branded formulations and CDMO businesses.
The company’s domestic branded formulations business has continued to outperform the broader market according to management commentary in recent quarters, with steady volume growth across key brands, including recently acquired portfolios, supporting the overall growth trajectory. Q1 FY27 detailed figures were not independently confirmed across public sources at the time of writing.
| Period | Revenue | Net Profit | Comment |
|---|---|---|---|
| Q4 FY26 (Mar 2026, most recently confirmed) | Rs 916.21 crore | Rs 101.37 crore | Latest confirmed quarter |
| FY26 (full year) | Rs 4,207.94 crore | Rs 709.47 crore | +6.4% revenue, +7.6% profit YoY |
Valuation Check: Is JB Chemicals and Pharmaceuticals Share Price Expensive?
This context matters for anyone assessing JB Chemicals share price today. It is one of the clearest signals available on JB Chemicals share price today. Any view on JB Chemicals share price should start from these valuation multiples. JB Chemicals share price currently reflects a price to earnings ratio of about 54.6 times trailing earnings, a premium to the broader pharmaceutical sector average of roughly 38 times. The price to book ratio stands near 9.3 times, supported by a solid 17.06 percent return on equity.
The company carries no debt, with a debt to equity ratio of 0.00. Historically, branded formulation companies with debt free balance sheets and consistent double-digit profit growth have commanded premium multiples, so the current premium reflects the market’s confidence in JB Chemicals’ brand portfolio and growing CDMO business, though it also means the stock has limited room for disappointment.
Technical Signals: What the Chart Shows
Watching JB Chemicals share price over consecutive sessions gives a clearer read than any single print. Price action here often foreshadows the next move in JB Chemicals share price. JB Chemicals share price is currently positioned just under 5 percent below its 52-week high of Rs 2,525.50 and roughly 47 percent above its 52-week low of Rs 1,638.50, reflecting a strong overall run over the past year. A stock trading this close to its annual high, backed by consistent full-year profit growth, typically signals continued market confidence in the underlying business.
Trading volumes remain modest for a stock of this price point, so investors should track JB Chemicals share price around the confirmation of Q1 FY27 detailed results, rather than reacting to any single day’s move at these technical levels.
Download the Univest iOS App or Univest Android App to track JB Chemicals’ live price and technical levels.
Shareholding Pattern
This detail is a useful reference point for JB Chemicals share price discussions. Shifts here can influence JB Chemicals share price more than headline news on some sessions. JB Chemicals and Pharmaceuticals has an institutional and public shareholder base that has evolved following past ownership transitions in the company’s history. A detailed current promoter, FII and DII percentage breakdown was not consistently available across sources at the time of writing and should be verified on the company’s latest exchange filing.
Why Investors Are Watching JB Chemicals and Pharmaceuticals
- Debt free balance sheet: A debt to equity ratio of 0.00 gives JB Chemicals significant financial flexibility to fund continued growth and CDMO investments.
- Consistent full-year growth: FY26 profit grew 7.6 percent year on year, continuing a steady multi-year growth trend across the company’s branded formulations business.
- Strong domestic brand performance: Management has highlighted that the domestic branded formulations business has outperformed the broader market in recent quarters.
- Growing CDMO opportunity: Investment in contract development and manufacturing capabilities provides a longer-term growth avenue beyond the core branded formulations business.
Risks and Factors to Watch
- Premium valuation: A 54.6x PE, a meaningful premium to the pharmaceutical sector average, leaves limited room for disappointment if growth were to slow.
- Unconfirmed recent quarterly data: Specific Q1 FY27 figures were not independently confirmed across public sources at the time of writing, adding some uncertainty until verified data becomes available.
- Sector-wide pricing and regulatory pressure: Like all pharmaceutical companies, JB Chemicals faces periodic drug pricing regulation and regulatory scrutiny across its domestic and export markets.
- CDMO execution risk: Successfully scaling the newer CDMO business requires continued investment and client acquisition, which carries inherent execution risk.
JB Chemicals and Pharmaceuticals Share Price Target: What the Data Suggests
Until then, JB Chemicals share price remains best tracked through live, verified data rather than a single fixed number. JB Chemicals does not have a single widely published, current analyst consensus 12-month share price target consistently available at this time. What the data shows through the most recently confirmed quarter is a debt free pharmaceutical company delivering steady growth, trading at a premium to the broader pharma sector.
Historically, branded pharmaceutical companies with strong domestic performance and growing CDMO operations have sustained premium valuations. Investors who want live, updated research can check the Univest Screener, and should consult a SEBI-registered investment adviser for guidance tailored to their own goals.
JB Chemicals and Pharmaceuticals: Should You Buy, Hold, or Sell Right Now?
There is no shortcut here: JB Chemicals share price needs to be judged against your own plan. This is the core question behind JB Chemicals share price right now. The JB Chemicals buy or sell decision depends on your confidence in the company sustaining its steady growth trajectory near current highs.
The case for buying: Investors who value the debt free balance sheet, consistent full-year growth, and strong domestic brand performance may see the stock’s proximity to its 52-week high as justified by fundamentals.
The case for holding: Existing shareholders who already track JB Chemicals’ steady execution may prefer to stay invested through confirmation of the next quarterly results.
The case for trimming or waiting: Valuation-sensitive investors, or those wanting confirmed Q1 FY27 figures before committing fresh capital, may prefer to wait for that data and a larger valuation cushion.
Historically, well-run branded pharmaceutical companies have rewarded patient investors, so weigh this against your own investment horizon and consult a SEBI-registered investment adviser if unsure.
Conclusion
In short, JB Chemicals share price calls for weighing these points together rather than in isolation. JB Chemicals and Pharmaceuticals share price reflects a debt free branded pharmaceutical company delivering steady full-year growth, trading near its 52-week high at a premium to the pharma sector. Whether that makes the stock a buy, a hold or a sell right now depends on your confidence in the growth trend continuing once the latest quarterly figures are confirmed. This article is for informational purposes and not a personalised investment recommendation.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Q1. Is JB Chemicals a good stock to buy right now?
Ans. JB Chemicals delivered steady FY26 growth, with profit up 7.6 percent year on year, and trades near its 52-week high at a premium to the pharma sector. This may appeal to investors who value the company’s debt free balance sheet and consistent execution, though confirmed Q1 FY27 figures would strengthen the picture.
Q2. What is the JB Chemicals share price today?
Ans. JB Chemicals and Pharmaceuticals share price is trading around Rs 2,409 on the NSE, close to its 52-week high of Rs 2,525.50. The stock’s 52-week low is Rs 1,638.50.
Q3. What is the JB Chemicals share price target?
Ans. JB Chemicals does not have a single widely published, current analyst consensus 12-month share price target consistently available at this time. Investors can check live research on the Univest Screener and consult a SEBI-registered adviser.
Q4. What is JB Chemicals’ latest confirmed quarterly performance?
Ans. JB Chemicals’ most recently confirmed quarter is Q4 FY26 (March 2026), with revenue of Rs 916.21 crore and net profit of Rs 101.37 crore, while full-year FY26 revenue grew 6.4 percent to Rs 4,207.94 crore with profit up 7.6 percent to Rs 709.47 crore.
Q5. What is JB Chemicals’ market capitalisation and PE ratio?
Ans. JB Chemicals has a market capitalisation of approximately Rs 38,731 crore and trades at a price to earnings ratio of about 54.6 times, a premium to the pharmaceutical sector average PE of roughly 38 times.
Q6. Is JB Chemicals debt free?
Ans. Yes, JB Chemicals carries a debt to equity ratio of 0.00, reflecting a conservative, debt free approach to funding its branded formulations and CDMO growth.
